Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pilot study of the effectiveness of the anaplerotic medication Triheptanoin in improving muscle strength in patients with sporadic Inclusion Body Myositis

Trial Profile

Pilot study of the effectiveness of the anaplerotic medication Triheptanoin in improving muscle strength in patients with sporadic Inclusion Body Myositis

Status: Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Triheptanoin (Primary)
  • Indications Inclusion body myositis
  • Focus Therapeutic Use
  • Sponsors Ultragenyx Pharmaceutical

Most Recent Events

  • 04 Mar 2014 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top